Concepedia

Cell-based Tolerance Therapy

Cell-Based Tolerance Therapy is a therapeutic strategy within autoimmune disease immunotherapy that employs engineered or modulated living cells to selectively suppress pathological immune responses while preserving overall immune competence, thereby inducing antigen-specific immune tolerance.

19

Publications

794

Citations

85

Authors

29

Institutions

Publications per year

2017–2026

4

Parents

Publications

19

T <sub>reg</sub> cells—the next frontier of cell therapy

Jeffrey A. Bluestone, Qizhi Tang · Science · 2018 · 151 citations

, , +16

Treatment of a Lysosomal Storage Disease, Mucopolysaccharidosis VII, with Microencapsulated Recombinant Cells

Colin J.D. Ross, Laila K. Bastedo, Stefan A. Maier et al. · Human Gene Therapy · 2000 · 88 citations

, , +16

Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities

Cassandra Smith, Stephen D. Miller · Journal of Autoimmunity · 2006 · 88 citations

, , +14

Comparison of Regulatory T Cells in Hemodialysis Patients and Healthy Controls

Behdad Afzali, Francis C. Edozie, Henrieta Fazekasova et al. · Clinical Journal of the American Society of Nephrology · 2013 · 73 citations · Full text

, , +17

Red blood cells as innovative antigen carrier to induce specific immune tolerance

Magali Cremel, Nathalie Guérin, Françoise Horand et al. · International Journal of Pharmaceutics · 2013 · 72 citations

, , +16

1–5 of 19

Authors

85

  1. WM
    Wood Ml

    Deaconess Hospital, United States

    2 publications · 39 citations

    2

    h-index

  2. NG
    Nathalie Guérin

    Erytech Pharma (France), France

    2 publications · 88 citations

    2

    h-index

  3. YG
    Yann Godfrin

    Erytech Pharma (France), France

    2 publications · 88 citations

    2

    h-index

  4. GJ
    Gozzo Jj

    Deaconess Hospital, United States

    2 publications · 39 citations

    2

    h-index

  5. MC
    Magali Cremel

    Erytech Pharma (France), France

    2 publications · 88 citations

    2

    h-index

1–5 of 85

Institutions

29

  1. University of Minnesota Medical Center

    Minneapolis, United States

    3 h-index

    8 publications

    332 citations

  2. Catholic University of Korea

    Seoul, South Korea

    2 h-index

    19 publications

    480 citations

  3. Erytech Pharma (France)

    Lyon, France

    2 h-index

    12 publications

    472 citations

  4. The Catholic University of Korea Seoul St. Mary's Hospital

    Seoul, South Korea

    2 h-index

    3 publications

    64 citations

  5. Rush University

    Chicago, United States

    1 h-index

    3 publications

    33 citations

  6. Cellular Therapeutics (United Kingdom)

    Manchester, United Kingdom

    1 h-index

    3 publications

    36 citations

  7. Research Manitoba

    Winnipeg, Canada

    1 h-index

    5 publications

    220 citations

  8. Poznan University of Medical Sciences

    Poznan, Poland

    1 h-index

    1 publications

    12 citations

1–8 of 29

Venues

  1. PubMed

    Repository · 2 publications · 39 citations

    2

    h-index

  2. International Journal of Pharmaceutics

    2 publications · 88 citations

    2

    h-index

  3. Experimental Biology and Medicine

    2 publications · 83 citations

    2

    h-index

  4. EBioMedicine

    1 publications · 16 citations

    1

    h-index

  5. Clinical Journal of the American Society of Nephrology

    CJASN · 1 publications · 73 citations

    1

    h-index

1–5